Serotonin: From sensory processing to schizophrenia using an electrophysiological method

Behavioural Brain Research

Volumn 277, Issue , 2015, Pages 121-124

  Juckel, Georg ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Auditory evoked potentials; Loudness dependence; Schizophrenia; Serotonin

Indexed keywords

CLOZAPINE; DOPAMINE RECEPTOR; LITHIUM SALT; NEUROLEPTIC AGENT; OLANZAPINE; SEROTONIN; SERTRALINE; ZIMELDINE;

DOPAMINERGIC TRANSMISSION; DRUG EFFECT; DRUG RECEPTOR BINDING; GABAERGIC SYSTEM; HUMAN; INTERNEURON; LOUDNESS DEPENDENCE OF AUDITORY EVOKED POTENTIAL; NEGATIVE SYNDROME; NERVOUS SYSTEM PARAMETERS; NONHUMAN; PATHOPHYSIOLOGY; PERCEPTION; PRIMARY AUDITORY CORTEX; PYRAMIDAL NERVE CELL; REVIEW; SCHIZOPHRENIA; SENSORY PROCESSING; SEROTONIN RELEASE; SEROTONINERGIC NERVE CELL; SEROTONINERGIC TRANSMISSION; ANIMAL; COGNITION; ELECTROSTIMULATION THERAPY; EVOKED AUDITORY RESPONSE; METABOLISM; PHYSIOLOGY; PROCEDURES; SYNAPTIC TRANSMISSION;

ANIMALS; COGNITION; ELECTRIC STIMULATION THERAPY; EVOKED POTENTIALS, AUDITORY; HUMANS; SCHIZOPHRENIA; SEROTONIN; SYNAPTIC TRANSMISSION;

EID: 84912091006     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.05.042     Document Type: Review

References (52)

1. Heninger G.R., Delgado P.L., Charney D.S. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry 1996, 29:2-11.
2. Malison R.T., Price L.H., Berman R., van Dyck C.H., Pelton G.H., Carpenter L., et al. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 betacarbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 1998, 44:1090-1098.
3. Willeit M., Praschak-Rieder N., Neumeister A., Pirker W., AsenbaumS, Vitouch O., et al. [123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiatry 2000, 7:482-489.
4. Tauscher J., Pirker W., Willeit M., de Zwaan M., Bailer U., Neumeister A., et al. [123I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa. Biol Psychiatry 2001, 49:326-332.
5. Pogarell O., Hamann C., Popperl G., Juckel G., Chouker M., Zaudig M., et al. Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder. Biol Psychiatry 2003, 54:1406-1413.
6. Nash J.F., Meltzer H.Y. Neuroendocrine studies in psychiatric disorders: the role of serotonin. The role of serotonin in psychiatric disorders 1991, 57-90. Brunner/Mazel, New York, NY. S.L. Brown, H.M. van Praag (Eds.).
7. Yatham L.N., Steiner M. Neuroendocrine probes of serotonergic function: a critical review. Life Sci 1993, 53:447-463.
8. Murphy D.L. Peripheral indices of central serotonin function in human. Ann N Y Acad Sci 1990, 600:282-296.
9. Moret C., Briley M. Platelet 3H-paroxetine binding to the serotonin transporter is insensitive to changes in central serotonergic innervation in the rat. Psychiatry Res 1991, 38:97-104.
10. Potter W.Z., Manji H.K. Are monoamine metabolites in cerebrospinal fluid worth measuring?. Arch Gen Psychiatry 1993, 50:653-656.
11. Zheng J., Wu X., Li L. Metabotropic glutamate receptors Q5 subtype 5 are necessary for the enhancement of auditory evoked potentials in the lateral nucleus of the amygdala by tetanic stimulation of the auditory thalamus. Neuroscience 2008, 152(1):254-264.
12. Javitt D.C., Schroeder C.E., Steinschneider M., Arezzo J.C., Ritter W., Vaughan H.G. Cognitive event-related potentials in human and non-human primates: implications for the PCP/NMDA model of schizophrenia. Electroencephalogr Clin Neurophysiol 1995, 44:161-175.
13. Hegerl U., Juckel G. Intensity dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission-a new hypothesis. Biol Psychiatry 1993, 33:173-187.
14. Juckel G., Hegerl U., Molnár M., Csépe V., Karmos G. Auditory evoked potentials reflect serotonergic neuronal activity-a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology 1999, 21:710-716.
15. Azmitia E.C., Gannon P.J. The primate serotonergic system: a review of human an animal studies and a report on Macaca fascicularis. Adv Neurol 1986, 43:407-468.
16. Lewis D.A., Campbell M.J., Foote S.L., Morrison J.H. The monoaminergic innervation of primate neocortex. Hum Neurobiol 1986, 5:181-188.
17. James L., Gordon E., Kraiuhin C., Howson A., Meares R. Augmentation of auditory evoked potentials in somatisation disorder. J Psychiatr Res 1990, 24:155-163.
18. Norra C., Tuchtenhagen F., Mrazek M., Gobbele R., Buchner H., Herpertz S., et al. Loudness dependence of auditory evoked dipole source activity in borderline personality. Electroencephalogr Clin Neurophysiol 1998, 107:53-54.
19. Rothenberger A., Blanz B., Lehmkuhl G. What happens to electric brain activity when anorectic adolescents gain weight?. Eur Arch Psychiatry Clin Neurosci 1991, 240:144-147.
20. Wang W., Timset-Berthier M., Schoenen J. Intensity dependence of auditory evoked potentials is pronounced in migraine: an indication of cortical potentiation and low serotonergic neurotransmission. Neurology 1996, 46:1404-1409.
21. Tuchtenhagen F., Daumann J., Norra C., Gobbele R., Becker S., Pelz S., et al. High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users. Neuropsychopharmacology 2000, 22:608-617.
22. Croft R.J., Klugman A., Baldeweg T., Gruzelier J.H. Electrophysiological evidence of serotonergic impairment in long-term MDMA ('ecstasy') users. Am J Psychiatry 2001, 158:1687-1692.
23. Mavorgiorgou P., Gohle D., Winter C., Rujescu D., Pogarell O., Mulert C., et al. Low serotonergic function and its normalization by treatment with sertraline in obsessive-compulsive disorder-an auditory evoked potential study. J Clin Psychopharmacol 2010, 30(3):341-343.
24. Buchsbaum M.S., Pfefferbaum A. Individual differences in stimulus intensity response. Psychophysiology 1971, 8:600-611.
25. Hubbard R., Judd L., Huey L., Kripke D., Janowsky D., Lewis A. Visual cortical evoked potentials in alcoholics and normals maintained on lithium carbonate: augmentation and reduction phenomena. Adv Exp Med Biol 1980, 126:573-577.
26. Von Knorring L. Effect of imipramine and zimelidine on the augmenting-reducing response of visual-evoked potentials in healthy volunteers. Adv Biol Psychiatry 1982, 9:81-86.
27. Juckel G., Gallinat J., Sokullu S., Riedel M., Schulz C., Müller H.J., et al. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res 2003, 64:115-124.
28. Gallinat J., Bottlender R., Juckel G., Munke-Puchner A., Stotz G., Kuss H.J., et al. The loudness dependence of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology 2000, 148:404-411.
29. Juckel G., Pogarell O., Augustin H., Mulert C., Müller-Siecheneder F., Frodl T., et al. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depression. J Clin Psychiatry 2007, 68:1206-1212.
30. Juckel G., Mavorgiorgou P., Gohle D., Winter C., Rujescu D., Pogarell O. Auditory evoked potentials as indicators of brain serotonergic activity: first evidence in cats. Biol Psychiatry 1997, 41:1181-1195.
31. Arezzo J.C., Vaughan H.G., Kraut M.A., Steinschneider M., Legatt A.D. Intracranial generators of event-related potentials in the monkey. Evoked potentials 1986, 174-189. Alan R Liss, New York, NY. R.Q. Cracco, I. Bodis-Wollner (Eds.).
32. Molnar M., Karmos G., Csepe V. Laminar analysis of intracortical auditory evoked potentials during the wakefulness-sleep cycle in the cat. Int J Psychophysiol 1986, 3:171-182.
33. Juckel G., Csépe V., Molnár M., Hegerl U., Karmos G. Intensity dependence of auditory evoked potentials in behaving cats. Electroencephalogr Clin Neurophysiol 1996, 100:527-537.
34. Barth D.S., Kithas J., Di S. Anatomic organization of evoked potentials in rat parietotemporal cortex: somatosensory and auditory responses. J Neurophysiol 1993, 69:1837-1849.
35. Sambeth A., Maes J.H., Van Luijtelaar G., Molenkamp I.B., Jongsma M.L., Van Rijn C.M. Auditory event-related potentials in humans and rats: effects of task manipulation. Psychophysiology 2003, 40:60-68.
36. Wutzler A., Winter C., Kitzrow W., Uhl I., Wolf R.J., Heinz A., et al. Loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission: simultaneous electrophysiological recordings and in vivo microdialysis in the rat primary auditory cortex. Neuropsychopharmacology 2008, 33:3176-3181.
37. Seeman P., Lee T., Chau Wong M., Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 1976, 261:717-719.
38. Meltzer H.Y. The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 1999, 21:106-115.
39. Sawa A., Snyder S.H. Schizophrenia: diverse approaches to a complex disease. Science 2002, 296:692-695.
40. Juckel G., Gudlowski Y., Muller D., Ozgurdal S., Brune M., Gallinat J., et al. Loudness dependence of the auditory evoked N1/P2 component as an indicator of serotonergic dysfunction in patients with schizophrenia-a replication study. Psychiatry Res 2008, 158:79-82.
41. Yung A.R., McGorry P.D. The prodromal phase of first episode psychosis: past and current conceptualisations. Schizophr Bull 1996, 22(2):353-370.
42. Klosterkotter J., Hellmich M., Steinmeyer E.M., Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001, 58(2):158-164.
43. Ruhrmann S., Schultze-Lutter F., Salokangas R.K., Heinimaa M., Linszen D., Dingemans P., et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry 2010, 67(3):241-251.
44. Pantelis C., Yucel M., Wood S.J., McGorry P.D., Velakoulis D. Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences. Aust NZ J Psychiatry 2003, 37(4):399-406.
45. Witthaus H., Mendes U., Brüne M., Ozgürdal S., Bohner G., Gudlowski Y., et al. Hippocampal subdivision and amygdalar volumes in patients in an at-risk mental state for schizophrenia. J Psychiatry Neurosci 2010, 35(1):33-40.
46. Juckel G., Friedel E., Koslowski M., Witthaus H., Ozgürdal S., Gudlowski Y., et al. Ventral striatal activation during reward processing in subjects with ultra-high risk for schizophrenia. Neuropsychobiology 2012, 66(1):50-56.
47. Gudlowski Y., Ozgürdal S., Witthaus H., Gallinat J., Hauser M., Winter C., et al. Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls. Psychiatry Res 2009, 173(3):163-169.
48. Wyss C., Hitz K., Hengartner M.P., Theodoridou A., Obermann C., Uhl I., et al. The loudness dependence of auditory evoked potentials (LDAEP) as an indicator of serotonergic dysfunction in patients with predominant schizophrenic negative symptoms. PLoS One 2013, 8(7):e68650.
49. Juckel G., Molnár M., Hegerl U., Csépe V., Karmos G. Auditory evoked potentials as indicators of brain serotonergic activity-first evidence in cats. Biol Psychiatry 1997, 41:1181-1195.
50. Hitz K., Heekeren K., Obermann C., Huber T., Juckel G., Kawohl W. Examination of the effect of acute levodopa administration on the loudness dependence of auditory evoked potentials (LDAEP) in humans. Psychopharmacology 2012, 221:389-396.
51. O'Neill B.V., Guille V., Croft R.J., Leung S., Scholes K.E., Phan K.L., Nathan P.J. Effects of selective and combined serotonin and dopamine depletion on the loudness dependence of the auditory evoked potential (LDAEP) in humans. Hum Psychopharmacol 2008, 23:301-312.
52. Uhl I., Gorynia I., Gallinat J., Mulert C., Wutzler A., Heinz A., Juckel G. Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects?. Hum Psychopharmacol 2006, 21:463-471.